Tramadol is an FDA-approved medication for pain relief. It has specific indications for moderate to severe pain. It is considered a class IV drug by the FDA and has been since July of 2014. Due to possible misuse disorder potential, limitations to its use should be for pain that is refractory to other pain medication, such as non-opioid pain medication. There are two forms of tramadol: extended-release and immediate release. This activity outlines the indications, mechanism of action, methods of administration, important adverse effects, contraindications, toxicity, and monitoring, of tramadol so providers can direct patient therapy where it is indicated as part of the interprofessional team.

**Objectives:**
- Identify the mechanism of action of tramadol.
- Review the various indications for tramadol.
- Summarize the adverse event profile of tramadol.
- Describe interprofessional team strategies for improving care coordination and communication to properly use tramadol to improve patient outcomes in the varied scenarios where it can be effective, with an eye towards the ongoing opioid crisis.